Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Fernex

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Schweizerische Medizinische Wochenschrift|December 10, 1988
[Malaria in Switzerland]M Fernex
Annales De Parasitologie Humaine Et Comparee|January 1, 1991
Resistance of internal and external parasites to antiparasitic drugsJ C Boray, M Fernex
Chemotherapy|January 1, 1988
Cefetamet pivoxil a new oral cephalosporin: clinical evaluationM Kissling, G Germano, M Fernex
Chemotherapy|January 1, 1976
Metabolic studies with 5-fluorocytosine-6-14C in mouse, rat, rabbit, dog and manA Polak, E Eschenhof, M Fernex, et al.
Infection|March 1, 1990
Short course single daily ceftriaxone monotherapy for acute bacterial meningitis in children: results of a Swiss multicenter study. Part I: Clinical resultsE Martin, P Hohl, T Guggi, et al.
Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis|January 22, 1991
[Current drugs for the treatment of tropical malaria]M Fernex, C Jaquet, M L Mittelholzer, et al.
Chemotherapy|February 15, 2001
Experimental in vitro efficacy study on the interaction of epiroprim plus isoniazid against Mycobacterium tuberculosisM Dosso, L Ouattara, A M Cherif, et al.
Bulletin of the World Health Organization|January 1, 1990
Interferon-alpha and synthetic peptide malaria sporozoite vaccine in non-immune adults: antibody response after 40 weeksD Stürchler, G Zimmer, R Berger, et al.
Antiviral Research|May 1, 1986
Intranasal interferon (rIFN-alpha A, Ro 22-8181) for contact prophylaxis against common cold: a randomized, double-blind and placebo-controlled field studyC Herzog, R Berger, M Fernex, et al.
European Journal of Clinical Microbiology|June 1, 1984
Interferon as an adjuvant for hepatitis B vaccination in non- and low-responder populationsP J Grob, H I Joller-Jemelka, U Binswanger, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Schweizerische Medizinische Wochenschrift|December 10, 1988
[Malaria in Switzerland]M Fernex
Annales De Parasitologie Humaine Et Comparee|January 1, 1991
Resistance of internal and external parasites to antiparasitic drugsJ C Boray, M Fernex
Chemotherapy|January 1, 1988
Cefetamet pivoxil a new oral cephalosporin: clinical evaluationM Kissling, G Germano, M Fernex
Chemotherapy|January 1, 1976
Metabolic studies with 5-fluorocytosine-6-14C in mouse, rat, rabbit, dog and manA Polak, E Eschenhof, M Fernex, et al.
Infection|March 1, 1990
Short course single daily ceftriaxone monotherapy for acute bacterial meningitis in children: results of a Swiss multicenter study. Part I: Clinical resultsE Martin, P Hohl, T Guggi, et al.
Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis|January 22, 1991
[Current drugs for the treatment of tropical malaria]M Fernex, C Jaquet, M L Mittelholzer, et al.
Chemotherapy|February 15, 2001
Experimental in vitro efficacy study on the interaction of epiroprim plus isoniazid against Mycobacterium tuberculosisM Dosso, L Ouattara, A M Cherif, et al.
Bulletin of the World Health Organization|January 1, 1990
Interferon-alpha and synthetic peptide malaria sporozoite vaccine in non-immune adults: antibody response after 40 weeksD Stürchler, G Zimmer, R Berger, et al.
Antiviral Research|May 1, 1986
Intranasal interferon (rIFN-alpha A, Ro 22-8181) for contact prophylaxis against common cold: a randomized, double-blind and placebo-controlled field studyC Herzog, R Berger, M Fernex, et al.
European Journal of Clinical Microbiology|June 1, 1984
Interferon as an adjuvant for hepatitis B vaccination in non- and low-responder populationsP J Grob, H I Joller-Jemelka, U Binswanger, et al.
Pageof 2